Biologic Contract Manufacturing WebinarPosted on May 28, 2024 |
 |
June 6, 2024, 10:00 a.m. – 12:00 p.m. EST
Michael Hausladen, PhD, General Manager,
LOTTE Biologics
Register in advance for this meeting here.
After registering, you will receive a confirmation email.
Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.
Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.
Other Member News
December 22, 2025M.A. Polce Named to MSSP Alert’s 2025 Top 250 Managed Security Service Providers List for Sixth Consecutive YearRecognized by CyberRisk Alliance and MSSP Alert, the annual Top 250 MSSPs ranking highlights the most influential and effective managed security service providers worldwide. |
December 19, 20252026 Medical Device Innovation Challenge (MDIC) PresentationLearn about the MDIC application and eligibility process, program timeline, Innovation Law Center prepared commercialization research, subject matter expert mentorship, and Ergami's perspective as a participant of the program. |
December 18, 2025Turning Stone Resort Casino’s 2025 Gingerbread Village Named One the World’s Most Over-the-Top Hotel Gingerbread Displays by Forbes Travel GuideThe “Holidays Around the World” themed village earns international acclaim and joins an impressive list of eight displays spanning the globe. |
